Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Ratio collects $70M for its radiopharmaceutical trials; Vogenx plans $67M IPO

Ratio Therapeutics raises $70M for radiopharma trials: The Boston biotech said the Series C funding came from existing investors Duquesne Family Office and Bristol Myers Squibb, as well as new ones ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 31 July →